By Jimmy Hoover ( March 2, 2018, 7:41 PM EST) -- Blue Cross Blue Shield of Massachusetts and three other insurers are fighting to keep a combined $67 million award in their long-running price-fixing suit against Mylan Pharmaceuticals and chemical companies Cambrex and Gyma Laboratories, asking the D.C. Circuit to reject the companies' latest appeal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.